Clinical Trials · NCT05064735

Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee Osteoarthritis

CompletedPhase 3Semaglutide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Novo Nordisk A/S
Enrollment
407
Start date
Oct 2021
Locations
122 sites, 11 countries
Primary endpoint
Percentage Change in Body Weight
View Semaglutide compound reference